C. Ernst et al. / Carbohydrate Research 338 (2003) 231–236
235
product was three times codistilled using toluene. The
resulting residue was purified by MPLC (9:1 cyclohex-
ane–EtOAc) to obtain 465 mg (87%) of compound 3
as a white powder: mp 168 °C; [h]2D0 −60.5° (c 1.4,
J5,CH3 6.2 Hz; 13C NMR (MeOD): l 172.96 (CꢀO),
103.68 (C-1), 77.85, 76.52, 73.34, 67.44 (C-2, C-3, C-4,
C-5), 55.91 (OCH3), 21.35 (C-6), 20.04 (Ac), 18.20
(3-CH3); ESIMS (positive-ion): m/z 257 [M+Na]+.
1
Et2O); H NMR (CDCl3): l 6.24 (d, 1H, H-1), 4.93 (d,
1H, H-4), 4.77 (d, 1H, H-2), 3.97 (dq, 1H, H-5), 2.55
(bs, 1H, OH), 2.16 (s, 3H, Ac), 1.31 (s, 3H, 3-CH3),
1.29 (d, 3H, 6-CH3); J1,2 6.1 Hz, J4,5 9.9 Hz, J5,CH3 6.3
Hz; 13C NMR (CDCl3): l 171.35 (CꢀO), 142.56 (C-1),
108.15 (C-2), 79.15 (C-4), 72.11 (C-5), 69.82 (C-3),
24.82 (C-6), 20.89 (Ac), 17.45 (3-CH3); ESIMS (posi-
tive-ion): m/z 209 [M+Na]+.
4.7. 1,5-Anhydro-2,6-dideoxy-3-C-methyl-4-O-methyl-
arabino-hex-1-enitol (7)
L-
L-Olivomycal (3) (600 mg, 4.2 mmol) was dissolved in
anhydrous DMF (30 mL) under Ar, and the solution
was cooled using an ice bath. NaH (167 mg, 4.2
mmol, 1 equiv, 60% dispersion in mineral oil) was
added, and the resulting mixture was stirred for 1.5 h.
The mixture was treated with MeI (259 mL, 4.2 mmol,
1 equiv) and stirred overnight. The solvent was then
evaporated, and the residue was dissolved in CH2Cl2
and extracted with water. The organic layer was dried
over MgSO4, the solvent evaporated, and the crude
residue was purified by MPLC (9:1 cyclohexane–
EtOAc) to give 194 mg (30%) of compound 7 as a
4.4. 4-O-Acetyl-1,5-anhydro-2,6-dideoxy-3-C-methyl-
ribo-hex-1-enitol (4)
L-
A solution of compound 2 (452 mg, 3.14 mmol) in
anhyd pyridine (30 mL) was treated with Ac2O (712
mL, 7.5 mmol, 2.4 equiv) and a catalytic amount of
DMAP under Ar, with cooling in an ice bath. After
stirring the resulting mixture at room temperature for
2 days, the solvent was evaporated, and the crude
product was dried in vacuo. The resulting residue was
purified by MPLC (12:1 cyclohexane–EtOAc) to yield
362 mg (62%) of compound 4 as a white powder: mp:
1
colourless oil. H NMR (CDCl3): l 6.19 (d, 1H, H-1),
4.65 (d, 1H, H-2), 3.81 (dq, 1H, H-5), 3.36 (s, 3H,
OCH3), 3.19 (d, 1H, H-4), 1.37 (d, 3H, 6-CH3), 1.33
(s, 3H, 3-CH3); J1,2 6.0 Hz, J4,5 10.0 Hz, J5,CH3 6.1 Hz;
13C NMR (CDCl3): l 142.56 (C-1), 108.33 (C-2), 86.94
(C-4), 73.45 (C-5), 71.74 (C-3), 61.06 (OCH3), 24.26
(C-6), 17.80 (3-CH3).
1
124 °C; H NMR (C6D6): l 5.44 (dd, 1H, H-1), 5.34
(d, 1H, H-4), 5.28 (d, 1H, H-2), 4.22 (dq, 1H, H-5),
1,70 (s, 3H, Ac), 1.49 (d, 3H, 3-CH3), 1.25 (d, 3H,
6-CH3); J1,2 3.3 Hz, J1,3-CH3 1.3 Hz, J4,5 8.9 Hz, J5,CH3
6.2 Hz; 13C NMR (C6D6): l 170.69 (CꢀO), 125.53
(C-1), 89.74 (C-2), 73.16 (C-4), 72.07 (C-3), 65.95 (C-
5), 20.66 (Ac), 18.57 (C-6), 18.24 (3-CH3); ESIMS
(positive-ion): m/z 209 [M+Na]+.
4.8. 1,2-Anhydro-6-deoxy-3-C-methyl-4-O-methyl-b-L-
mannopyranose (8)
Compound 8 was prepared according to the general
epoxidation protocol. The regio- and stereoselective
product formation was proven by hydrolysis to com-
pound 9.
4.5. 4-O-Acetyl-1,2-anhydro-6-deoxy-3-C-methyl-b-L-
mannopyranose (5)
Compound 5 was prepared according to the general
epoxidation protocol. The regio- and stereoselective
product formation was proven by methanolysis to
compound 6.16
4.9. 6-Deoxy-3-C-methyl-4-O-methyl-a-L-mannopyran-
ose (9)
The formerly prepared 1,2-anhydro sugar 8 (87 mg,
0.5 mmol) was dissolved in water and stirred for 1 h
at room temperature. The solvent was evaporated, and
the residue was purified by MPLC (1:3 cyclohexane–
EtOAc) to yield 58 mg (60%) of compound 9 as a
white powder: mp 156 °C (dec.); [h]2D0 −9.0° (c 1.0,
4.6. Methyl 4-O-acetyl-6-deoxy-3-C-methyl-a-L-
mannopyranoside (6)
The formerly prepared 1,2-anhydro sugar 5 (101 mg,
0.5 mmol) was dissolved in anhyd MeOH (5 mL) and
stirred for 3 h at room temperature. The solvent was
evaporated, and the residue was purified by MPLC
(4:1 cyclohexane–EtOAc) to yield 34 mg (30%) of
compound 6 as a colourless oil. [h]2D0 −75.0° (c 1.0,
1
MeOH); H NMR (MeOD): l 4.76 (d, 1H, H-1), 3.48
(s, 3H, OCH3), 3.33 (d, 1H, H-2), 3.24 (dq, 1H, H-5),
2.99 (d, 1H, H-4), 1.19 (d, 3H, 6-CH3), 1.10 (s, 3H,
3-CH3); J1,2 1.2 Hz, J4,5 9.5 Hz, J5,CH3 6.0 Hz; 13C
NMR (MeOD): l 94.43 (C-1), 87.05 (C-2), 78.43 (C-
4), 72.16 (C-3), 62.18 (C-5), 49.9 (OCH3), 19.12, 19.02
(C-6, 3-CH3); ESIMS (positive-ion): m/z 215 [M+
Na]+.
1
MeOH); H NMR (MeOD): l 4.91 (d, 1H, H-4), 4.63
(d, 1H, H-1), 3.73 (dq, 1H, H-5), 3.48 (d, 1H, H-2),
3.36 (s, 3H, OCH3), 2.09 (s, 3H, Ac), 1.29 (s, 3H,
3-CH3), 1.19 (d, 3H, 6-CH3); J1,2 1.4 Hz, J4,5 9.9 Hz,